Axcan To Pay Up To $230M For Rival Mpex
By Samuel Howard ( April 14, 2011, 4:57 PM EDT) -- Specialty pharmaceuticals company Axcan Holdings Inc. said Thursday it had agreed to pay as much as $230 million to acquire Mpex Pharmaceuticals Inc. and develop Mpex's Aeroquin treatment for pulmonary infections in cystic fibrosis patients....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.